Stevanato Group S.p.A. reported unaudited financial results for the three and nine months ended September 30, 2026. For the third quarter, revenue increased to €326.1 million from €303.2 million in the prior year period, while net profit rose to €41.8 million compared to €36.1 million. Operating profit for the quarter was €60.3 million, up from €52.7 million. For the first nine months of 2026, revenue reached €901.6 million against €839.8 million in the same period last year, with net profit at €92.8 million versus €92.3 million. The company operates in the pharmaceutical packaging industry, manufacturing primary packaging components such as vials and pre-filled syringes.
